The present situation, challenges, and perspectives regarding the production and utilization of effective drugs against human Chagas disease

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 47, Issue 1, 2014, Pages 123-125

  Dias, João Carlos Pinto ^a,b   Coura, Jose Rodrigues ^a,b   Yasuda, Maria Aparecida Shikanai ^b,c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Laboratório de Doenças Parasitárias Instituto Oswaldo Cruz Fundação Oswaldo Cruz ^*

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; NIFURTIMOX;

CARDIOMYOPATHY; CHAGAS DISEASE; DRUG MANUFACTURE; DRUG UTILIZATION; HEALTH CARE; HUMAN; LETTER; PUBLIC HEALTH; TABLET;

CHAGAS DISEASE; DRUG COMBINATIONS; DRUG DESIGN; HUMANS; NIFURTIMOX; NITROIMIDAZOLES; TRYPANOCIDAL AGENTS; WORLD HEALTH ORGANIZATION;

EID: 84895729997     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/0037-8682-0248-2013     Document Type: Letter

References (10)

1. Coura JR, Castro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 2002; 97:3-24.
2. Dias JCP, Macedo VO. Doença de Chagas. In: Coura JR, editor. Dinâmica das doenças infecciosas e parasitárias. Rio de Janeiro: Guanabara Koogan; 2005. p. 557-594.
3. Andrade JP, Marin-Neto JA, Paola AA, Vilas-Boas F, Oliveira GM, Bacal F, et al. Diretriz Latino Americana para o Diagnóstico e Tratamento da Cardiopatia Chagásica. (Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy). Arq Bras Cardiol 2011; 97 (supl II):1-47.
4. Ministério da Saúde. Consenso Brasileiro em Doença de Chagas. Rev Soc Bras Med Trop 2005; 38 (supl III):7-29.
5. Medeiros FPM. Current situation and new perspectives for the treatment of Chagas disease. Prospects for production and distribution of benznidazole. Rev Soc Bras Med Trop 2009; 42 (supl II):79.
6. Navarro M, Norman FF, Pérez-Molina JA, López-Vélez R. Benznidazole shortage makes Chagas disease a neglected tropical disease in developed countries: data from Spain. Am J Trop Med Hyg 2012; 87:489-490.
7. Brazilian Society on Tropical Medicine. O impacto mundial da interrupção da produção do benznidazol pelo Brasil: como contornar a crise de desabastecimento? Official motion from the 27th international meeting on Chagas Disease applied research (Uberaba, Brazil) addressed to the Brazilian Ministry of Health and the Scientific Community; 2011. Available at: http://blogdeparasitologia.files.wordpress.com/2011/11/ mocao_da_xxvii_reuniao_anual_de_pesquisa_aplicada_em_doenca_de_ chagas_20111.pdf
8. World Health Organization. Pan American Health Organization. INCOSUR. Final report and conclusions of the XIX Intergovernmental Meeting. Santiago de Chie, October 8: Mimeog; 2013.
9. Sosa-Estani S. La producción de benznidazol en Argentina. Oficial report to the XIX Reunión de la Comisión Intergubernamental (CI) de la Iniciativa Subregional Cono Sur de Eliminación de Triatoma infestans y Interrupción de la Transmisión Transfusional de la Tripanosomiasis Americana. Termas de Rio Hondo, Argentina, Octubre 8; 2013.
10. Rezende KS. Producción Brasileña de Medicamentos y Ingrediente Activo de Benznidazol. Official report to the XIX Reunión de la Comisión Intergubernamental (CI) de la Iniciativa Subregional Cono Sur de Eliminación de Triatoma infestans y Interrupción de la Transmisión Transfusional de la Tripanosomiasis Americana. Termas de Rio Hondo, Argentina, Octubre 8; 2013.